Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.5M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
9.89M
-
Shares change
-
+201K
-
Total reported value, excl. options
-
$147M
-
Value change
-
+$2.99M
-
Number of buys
-
19
-
Number of sells
-
-18
-
Price
-
$14.90
Significant Holders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) as of Q1 2021
51 filings reported holding TELA - TELA Bio, Inc. - Common Stock, par value $0.001 per share as of Q1 2021.
TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.89M shares
of 44.5M outstanding shares and own 22.21% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (3.03M shares), Essex Woodlands Management, Inc. (1.58M shares), RTW INVESTMENTS, LP (1.38M shares), PURA VIDA INVESTMENTS, LLC (421K shares), VANGUARD GROUP INC (420K shares), COWEN AND COMPANY, LLC (401K shares), Opaleye Management Inc. (365K shares), BlackRock Inc. (312K shares), Pentwater Capital Management LP (275K shares), and ARMISTICE CAPITAL, LLC (250K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.